Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors

Recombinant Towne CMV expressing luciferase under the control of CMV-DNA polymerase (POL) or the late pp28 (UL99) promoters were evaluated for potential application in high-throughput screening of anti-viral compounds. POL-and pp28-luciferase displayed maximal expression 48 and 72 hours post infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ran, Sandford, Gordon, Hayward, Gary S, Burns, William H, Posner, Gary H, Forman, Michael, Arav-Boger, Ravit
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041771/
https://www.ncbi.nlm.nih.gov/pubmed/21269468
http://dx.doi.org/10.1186/1743-422X-8-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041771/
https://www.ncbi.nlm.nih.gov/pubmed/21269468
http://dx.doi.org/10.1186/1743-422X-8-40

Ejemplares similares